Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
What should marketing and medical affairs invest in for Q4?
Join Jade and Isabel as they explore the critical trends that have shaped the industry in 2024 and what teams should leverage in Q4.
Read more
Creating winning pharma communications
Silvia Taylor, Executive Vice President and Chief Communications Officer, Novavax, discusses her passion for engaging the world in the wonder of science.
How to enhance value and access across pharma
In this episode, the GOLD team shares a conversation with Christoph Glaetzer, Chief Global Value and Access Officer, Johnson & Johnson.
Inspiring innovation and the future of digital therapeutics
Helena and Jade introduce a discussion on the future of digital therapeutics with Eugene Borukhovich, Co-Founder and COO, YourCoach.Health.
Pharma insights from the team behind GOLD
Listen to the GOLD team: Helena, Isabel and Jade will discuss key articles, themes and insights from the latest issue of GOLD.
Driving confidence and participation in genetic research
In this episode, Helena and Isabel are joined by Patrick Short, CEO, Sano Genetics, to discuss the challenges and opportunities facing genetic medicine.
Meet GOLD's next catalyst – Reshema Kemps-Polanco
Helena and Isabel speak to GOLD catalyst interviewee Reshema Kemps-Polanco, Executive Vice President and US Head, Novartis Oncology.
Unpicking pharma’s reputation in pop culture
Helena is joined by Paul Simms, CEO, Impatient Health, to delve deeper into GOLD’s cover feature on reframing pharma’s bad boy reputation.
In conversation with GSK's Rino Rappuoli
This week, Helena and Isabel are honoured to be joined by Rino Rappuoli, Head of External R&D and Chief Scientist at GSK Vaccines.
Loading posts...
« Previous
1
…
6
7
8
9
10
…
23
Next »